An investigational once-weekly amylin receptor agonist conferred substantial weight loss across six different dosing regimens for adults with overweight or obesity, researchers reported in a phase 2 ...

Weight-loss drugs are back in the news, thanks to the emergence of a bidding war between industry heavyweights Novo Nordisk ...

A next-generation CT5 has already been confirmed, but GM's Alpha platform plans may not stop there.

Enrollment to date of 100 patients, with 80 patients completing treatment in the ongoing Halneuron® Phase 2b trial, ...

NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, and led by Professor Paolo A. Ascierto of the Istituto ...

Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulatorDeepens Axsome’s broad ...

Patients with T2D and inflammatory arthritis who received GLP-1 RAs vs SGLT2 inhibitors had lower rates of hypoglycemia, serious infections, and AKI.

Officials revealed that there was an excess concentration of this chemical in the capsules, which could be deadly to the ...

-- STK-012 is an <ALPHA>/<BETA> biased IL-2 designed to specifically stimulate antigen activated T cells -- Results from an ongoing Phase 1a/1b to be presented at SITC -- Company will also present new ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. | ...

A research team systematically identified and characterized 15 ABA receptor genes (SlPYR/PYLs) in tomato, highlighting ...

While not risk-free, natural leaf kratom offers an accessible option, and many users report that it helps them regain control of their lives.